Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-22

Clinical Trial Update: Transcendental Meditation and PTSD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Transcendental Meditation for PTSD and depressive symptoms is in progress, with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcendental Meditation

Snippet

Sponsor: David Lynch Foundation | Conditions: Ptsd, Depressive Symptoms | Phase 3 | Status: UNKNOWN